NCT06649838View on ClinicalTrials.gov

Customized Circulating Tumor DNA Testing for Cervical Cancer Recurrence Surveillance and Treatment Decisions

Not yet recruitingOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

December 20, 2024

Primary Completion Date

March 2, 2025

Study Completion Date

October 2, 2026

Conditions
ImmunotherapyCervical CancerCtDNABiomarker
All Listed Sponsors
lead

Peking Union Medical College Hospital

OTHER